For example, p.Gly17Val mutations in the RHOA gene encoding for T-Cell cytoskeleton regulation have been shown to be counteracted by the multikinase inhibitor dasatinib in AITL and PTCL-NOS [76]. Here, RHOA is linked to angioimmunoblastic T-cell lymphoma.